YoVDO

HRD Evaluation and Scoring Using OncoScan CNV Assay - A Whole-Genome Microarray Research Solution

Offered By: Labroots via YouTube

Tags

Genomics Courses Biomarkers Courses Breast Cancer Courses Ovarian Cancer Courses

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Attend a panel presentation webinar featuring Yann Christinat, PhD and Stephan Bartels, PhD discussing homologous recombination deficiency (HRD) evaluation and scoring using the OncoScan CNV Assay. Explore how this whole-genome microarray research solution can be used as an alternative to NGS for detecting genome-wide HRD biomarkers in high-grade ovarian and breast cancers. Learn about the correlation between HRD scores and PARP inhibitor response, and discover how OncoScan detects Long Scale State transitions (LST), Loss of Heterozygosity (LOH), Telomeric Allelic Imbalance (TAI), and Whole Genome Doubling (WGD) events to create HRD Scores. Participate in a live Q&A session following the presentation to further explore this innovative approach to cancer research and potential therapeutic applications.

Syllabus

Panel Presentation: HRD Evaluation and Scoring Using OncoScan CNV Assay, a Whole-Genome Micro...


Taught by

Labroots

Related Courses

El abordaje multidisciplinar de las demencias
Universidad de Cantabria via Miríadax
Demystifying Targeted Cancer Treatments
Cancer Research UK via FutureLearn
Diagnosis and prognosis biomarkers in global health
Institut Pasteur via France Université Numerique
Extracellular Vesicles in Health and Disease
University of California, Irvine via Coursera
Procalcitonin: PCT as a Biomarker for Antimicrobial Stewardship
The British Society for Antimicrobial Chemotherapy via FutureLearn